Literature DB >> 27446466

Recurrent retroperitoneal inflammatory myofibroblastic tumor: A case report.

Xinjun Wang1, Xiaokun Zhao2, Joseph Chin3, Liang Zhu2, Zijian Wang2, Zhaohui Zhong2.   

Abstract

Inflammatory myofibroblastic tumor (IMT), which was previously known as inflammatory pseudotumor, is characterized by myofibroblastic spindle cells accompanied by inflammatory infiltrates. IMT is a rare lesion of unclear etiology, which induces non-specific clinical symptoms. The present case report describes a 74-year-old female patient with recurrent IMT, which was successfully re-resected 30 months subsequent to initial surgical removal. The patient presented with left hydroureteronephrosis and a 10-cm paravertebral mass which, upon surgery, was found to involve the descending colon. Successful, complete en bloc re-resection was achieved, and at 24 months follow-up, the patient remained clinically free of disease. Complete surgical extirpation, where feasible, is the recommended treatment for primary and recurrent IMT lesions.

Entities:  

Keywords:  recurrent; retroperitoneal inflammatory myofibroblastic tumor; surgery

Year:  2016        PMID: 27446466      PMCID: PMC4950583          DOI: 10.3892/ol.2016.4767

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  15 in total

1.  Regression of nonresectable inflammatory myofibroblastic tumours after treatment with nonsteroidal anti-inflammatory drugs.

Authors:  R Przkora; U Bolder; S Schwarz; K W Jauch; J Spes; R Andreesen; A Mackensen
Journal:  Eur J Clin Invest       Date:  2004-04       Impact factor: 4.686

2.  Retroperitoneal inflammatory myofibroblastic tumor.

Authors:  Stamatios Chatzikokolis; Theodore G Troupis; Adamantios Michalinos; Nikolaos Bafaloukas; Theodoros Filippidis; Vassilios Gennimatas
Journal:  Am Surg       Date:  2012-03       Impact factor: 0.688

3.  Abdominal inflammatory myofibroblastic tumour.

Authors:  S Aptel; A Gervaise; A Fairise; P Henrot; A Leroux; F Guillemin; V Laurent; D Régent
Journal:  Diagn Interv Imaging       Date:  2012-04-03       Impact factor: 4.026

4.  Retroperitoneal myofibroblastic inflammatory tumor.

Authors:  Sonia Ziadi; Mounir Trimeche; Sarra Mestiri; Nadia Boujelbene; Moncef Mokni; Badreddine Sriha; Sadok Korbi
Journal:  Tunis Med       Date:  2011-04

5.  Inflammatory tumour of the retroperitoneum--a case report.

Authors:  V P Mali; H C Tan; D Loh; K Prabhakaran
Journal:  Ann Acad Med Singap       Date:  2005-11       Impact factor: 2.473

6.  Inflammatory myofibroblastic tumor successfully treated with chemotherapy and nonsteroidals: a case report.

Authors:  Yun-Lu Tao; Zhen-Jun Wang; Jia-Gang Han; Ping Wei
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

7.  Retroperitoneal inflammatory myofibroblastic tumor.

Authors:  Rabin Koirala; Vikal C Shakya; Chandra S Agrawal; Sudeep Khaniya; Sagar R Pandey; Shailesh Adhikary; Om P Pathania
Journal:  Am J Surg       Date:  2009-10-17       Impact factor: 2.565

8.  Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.

Authors:  Cheryl M Coffin; Jason L Hornick; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2007-04       Impact factor: 6.394

Review 9.  Inflammatory myofibroblastic tumours: where are we now?

Authors:  B C Gleason; J L Hornick
Journal:  J Clin Pathol       Date:  2007-10-15       Impact factor: 3.411

10.  Complete remission of ALK-negative plasma cell granuloma (inflammatory myofibroblastic tumor) of the lung induced by celecoxib: A case report and review of the literature.

Authors:  Cinderella Chavez; Mark A Hoffman
Journal:  Oncol Lett       Date:  2013-03-15       Impact factor: 2.967

View more
  2 in total

1.  Giant fibroepithelial polyp of the thigh and retroperitoneal fibromatosis in a young woman: a rare case.

Authors:  Ruchi Gupta; Shuchi Smita; Ruchi Sinha; Neetu Sinha; Lakshmi Sinha
Journal:  Skeletal Radiol       Date:  2018-02-27       Impact factor: 2.199

2.  Case Report: Recurrence of Testicular Myofibroblastic Tumor After Surgery.

Authors:  Jiayi Liu; Zhijie Bai; Shuaiqi Li; Sheng Zeng; Chuang Li; Qian Liu
Journal:  Front Oncol       Date:  2022-01-14       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.